Phase 1 study of bortezomib in combination with melphalan and dexamethasone in Japanese patients with relapsed AL amyloidosis
Crossref DOI link: https://doi.org/10.1007/s12185-015-1901-2
Published Online: 2015-11-20
Published Print: 2016-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shimazaki, Chihiro
Fuchida, Shin-ichi
Suzuki, Kenshi
Ishida, Tadao
Imai, Hirokazu
Sawamura, Morio
Takamatsu, Hiroyuki
Abe, Masahiro
Miyamoto, Toshihiro
Hata, Hiroyuki
Yamada, Masahito
Ando, Yukio
Text and Data Mining valid from 2015-11-20